Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα

OBJECTIVE: Type II nuclear hormone receptors, including farnesoid X receptors (FXR), liver X receptors (LXR), and peroxisome proliferator-activated receptors (PPAR), which serve as drug targets for metabolic diseases, are permanently positioned in the nucleus and thought to be bound to DNA regardles...

Descripción completa

Detalles Bibliográficos
Autores principales: Kain, Jessica, Wei, Xiaolong, Reddy, Nihal A., Price, Andrew J., Woods, Claire, Bochkis, Irina M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350412/
https://www.ncbi.nlm.nih.gov/pubmed/34246806
http://dx.doi.org/10.1016/j.molmet.2021.101291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350412/
https://www.ncbi.nlm.nih.gov/pubmed/34246806
http://dx.doi.org/10.1016/j.molmet.2021.101291

Ejemplares similares